PATIENT SITE
redo
VERACYTE PORTAL
redo
WHY AFIRMA
LATEST NEWS AND EVIDENCE
EVENTS
PRACTICE RESOURCES
MENU
WHY AFIRMA
LATEST NEWS AND EVIDENCE
EVENTS
PRACTICE RESOURCES
VERACYTE PORTAL
PATIENT SITE
LATEST NEWS AND EVIDENCE
Get the latest news about Afirma and managing thyroid nodules
Afirma Clinical Experience
Development Research
Notable Topics
Article Types:
Interviews
Publications
Interview with Peter M. Sadow, MD, PhD: Detecting Expressed Variants and Fusions in RNASeq Data from Thyroid FNAs
READ MORE
Interview with Christian Nasr, MD: Independent Academic Medical Center Afirma GSC Experience
READ MORE
USPSTF Highlights Surgery Risks of Overtreatment of Thyroid Nodules
September 2017
READ MORE
New Research Suggests an "Omnigenic" Model Drives Complex Diseases
August 2017
READ MORE
Are Flame Retardant Chemicals Contributing to the Increase in Thyroid Cancer Cases?
July 2017
READ MORE
Interview with Michael Shanik, MD: Comparison of Local and Central Histopathology Panel from a Multicenter, Blinded Study
April 2017
READ MORE
Interview with Peter M. Sadow, MD, PhD: NIFT-P Nodules Result Afirma GEC Suspicious, Facilitating Surgical Treatment
April 2017
READ MORE
A Paradigm Shift to Reduce Overtreatment of Indolent Tumors [1]
November 2016
READ MORE
Meta-review Finds That RAS PPV Is Lower Than Previously Reported
July 2016
READ MORE
Contact us today
Monday to Friday, 5:30 AM – 5:00 PM (PST)
Phone: 1.888.923.4762
International: +1.650.243.6335
Fax: 650.243.6388
support@veracyte.com